Together Biotech, 5G and IoT Will Change The World As We Know It
The biotech industry is one of the fastest-growing and most innovative industries.
The company recently made a biotech partnership with pharmaceutical giants Bristol-Myers Squibb and Pfizer to create a new technology that can detect the earliest signs of a stroke.
And that’s not all!
Biotech is making huge strides across the market thanks to 5G and advancements in genomic sequencing.
Overall, biotech is a sector on the rise.
And one reason is lower interest rates. See, when interest rates are lower, people are more likely to buy into speculative stocks — and biotech is one of the most speculative sectors on the market.
So, when the sector takes a turn toward profit, you can take home incredible gains in just one day!
Bold Profits readers have taken home 29% in a biotech stock in just one single day. And that’s just the beginning… They’ve locked in total gains of:
Watch this week’s Market Talk below to find out how you can make fast profits like these:
Healthcare Will Benefit Tremendously From These Advancements
Last week I visited with a longtime family friend and while talking with them I noticed they suddenly had trouble speaking and appeared confused. Immediately I suspected they were suffering from a stroke and I acted FAST.
In stroke emergencies the acronym FAST means Face, Arm, Speech and Time. Thank goodness our dear friend received expedited medical care and the hospital physicians were able to administer medication that put them on the path to recovery.
I am happy to report they are back home feeling much better. This personal story brings me to a recent announcement from Fitbit Inc., the maker of wearable technology devices. Fitbit just announced a biotech partnership with the Bristol-Myers Squibb-Pfizer Alliance focused on the detection of atrial fibrillation (AFib) using Fitbit’s electrocardiogram outfitted devices.
Per MarketWatch, as AFib is a risk factor for stroke, the goal is to use technology to help patient’s detect this form of irregular heartbeat early on. Dr. Joseph Eid, head of medical at Bristol-Myers Sqibb said, “Too many people discover that they are suffering from AFib only after experiencing a stroke.”
“In fact, some studies suggest that this is true for more than 25% of people who have the condition.” With that, I can tell you that I will be buying a wearable device outfitted with an ECG for my dear friend today. As an owner of a smartwatch with ECG capability, I can save having a monitor of your daily heartrate and basic health is most beneficial.
Apparently I am not alone. I was just looking at markets and they are saying the wearable tech market is growing at a compounding annual growth rate of 15.5% and expected to reach $51.6 billion by 2022.
Now to our Good News Roundup stories. Good News Roundup story number one: As reported by Consumer Affairs, “foreclosure activity, default notices, scheduled auctions and bank repossessions all feel to a 14-year low in the third quarter of the year suggesting significant stability in the housing market.”
Good News Roundup story number two: HousingWire is reporting that “cheap rates will push 2019 mortgage volume past $2 trillion. This trend line shows we may be heading toward a 12-year high in lending volume.”
Good News Roundup story number three: Per Science Daily, if you want to live longer, especially among heart attack and stroke survivors, get a dog. “Dog ownership was associated with 33% lower risk of early death for heart attack survivors living alone and 27% reduced risk for stroke survivors living alone compared to people who did not own a dog.”
“Dog ownership was associated with a 24% reduced risk of all caused mortality and a 31% reduced risk for death by heart attack or stroke compared to non-owners.” As a dog owner, as you can see in this photo of my dog Alex, they are truly your best friend.
For more of my thoughts on investing and industry news as it happens, be sure to follow me on Twitter @MampillyGuru.
And don’t forget to watch my Bold Profits Daily video tomorrow for three biotech stock sectors skyrocketing in a new bull market — and your way to buy in now.
Editor, Profits Unlimited
I’ve been investing for more than 25 years. I started my career on Wall Street in 1991 as an assistant portfolio manager at Bankers Trust. I quickly advanced to prominent positions at Deutsche Bank and ING, managing multimillion-dollar accounts. In 2006, the owners of a $6 billion firm named Kinetics Asset Management recruited me to manage their hedge fund.